.Challenges in Cell Therapy: Relapse and Toxicities|
November 5, 2020
Addressing Relapsed Disease Following Hematopoietic Stem Cell Transplantation
John F. DiPersio, MD PhD
John F. DiPersio, MD PhD
1Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO
Search for other works by this author on:
Blood (2020) 136 (Supplement 1): SCI1.
Citation
John F. DiPersio; Addressing Relapsed Disease Following Hematopoietic Stem Cell Transplantation. Blood 2020; 136 (Supplement 1): SCI1. doi: https://doi.org/10.1182/blood-2020-133093
Download citation file: